News

Diamond skin disease, an infection that causes significant pain and discomfort and can be fatal if untreated, is a serious...

Vienna, Austria – Last month at the European League Against Rheumatism (EULAR) 2024 conference, UCB presented compelling two-year data from...

Guggenheim Partners has commenced coverage on Alumis Inc. (NASDAQ ), a clinical-stage biopharmaceutical firm focused on developing oral therapies for...

A recent meta-analysis published in JAMA Dermatology has found that smoking, older age, higher BMI, and previous exposure to biologics...

A breakthrough treatment for facial eczema is moving closer to reality, thanks to groundbreaking research by Dr. Tanushree Barua Gupta,...

In a significant advancement in eczema treatment, a novel topical pan-Janus kinase (JAK) inhibitor has demonstrated notable efficacy in alleviating...

A recent review of biologic therapies for pediatric psoriasis by Dr. Laura E. Melnick, an assistant professor of clinical dermatology...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration...

New Study Presented at 2024 EULAR Congress Highlights Potential Breakthrough Recent research unveiled at the 2024 EULAR Congress suggests that...

Treatment with oral dimethyl fumarate has led to notable improvements in disease classification criteria for patients with plaque psoriasis, according...